Yu-Chang John Wang

Title: Innovations of Yu-Chang John Wang

Introduction

Yu-Chang John Wang is a notable inventor based in Los Altos, CA. He has made significant contributions to the field of controlled release drug delivery systems. With a total of 2 patents, his work focuses on innovative hydrogel compositions and methods for the administration of growth factors.

Latest Patents

One of his latest patents is titled "Hydrogel compositions for the controlled release administration of growth factors." This invention discloses compositions and methods for the controlled release delivery of polypeptide growth factors. The hydrogels comprise a polypeptide growth factor with at least one region of positive charge, a physiologically acceptable water-miscible anionic polymer, a physiologically acceptable non-ionic polymeric viscosity controlling agent, and water. Another significant patent is "Controlled release delivery of peptide or protein." This invention involves compositions and devices for the controlled release delivery of a peptide or protein drug. It is produced by dispersing a glassy matrix phase containing the peptide or protein drug and a thermoprotectant in a bioerodable, biocompatible polymer at a specific temperature.

Career Highlights

Yu-Chang John Wang is currently associated with Scios Inc., where he continues to innovate in the field of drug delivery systems. His work has the potential to significantly impact therapeutic applications, particularly in the local delivery of angiogenic factors.

Collaborations

He has collaborated with notable colleagues, including Bing Yang and Robert N Jennings, Jr. These collaborations have likely contributed to the advancement of his research and innovations.

Conclusion

Yu-Chang John Wang's contributions to the field of controlled release drug delivery systems highlight his innovative spirit and dedication to improving therapeutic methods. His patents reflect a commitment to advancing medical technology and enhancing patient care.